Potential biomarkers in endometrial cancer: a narrative review

被引：8

作者：

Moar, Kareena ^{[1
]}

Pant, Anuja ^{[1
]}

Saini, Vikas ^{[2
]}

Maurya, Pawan Kumar ^{[1
]}

机构：

[1] Cent Univ Haryana, Dept Biochem, Mahendragarh 123031, India

[2] Cent Univ Haryana, Dept Vocat Studies & Skill Dev, Biomed Sci, Mahendragarh, India

来源：

BIOMARKERS | 2023年 / 28卷 / 04期

关键词：

Endometrial cancer; biomarker; mutation; classification; angiogenic factors; MISMATCH REPAIR-DEFICIENCY; POLYCYSTIC-OVARY-SYNDROME; ORAL-CONTRACEPTIVES; BREAST-CANCER; IMMUNOHISTOCHEMICAL EXPRESSION; RECEPTOR-ALPHA; LYNCH SYNDROME; CARCINOMA; RISK; ESTROGEN;

D O I：

10.1080/1354750X.2023.2179114

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

ContextEvery year, approximately 0.4 million women suffer from endometrial cancer (EC) worldwide and it has become the most common gynecological malignancy. Almost 66% of EC cases are diagnosed at an early stage and can be cured by performing surgery while those at an advanced stage turns out to be fatal. Biomarkers of endometrial cancer would be very valuable for screening of women who are at high risk and in detecting the chance of recurrence of disease.ObjectiveThe current article has reviewed studies published on expression of biomarkers and susceptibility to EC.MethodsGoogle Scholar and PubMed were used as searching platforms and we have majorly considered the literature from last 10 years.ResultsPotential biomarkers of EC identified from various studies were summarised.

引用

页码：358 / 371

页数：14

共 50 条

[21] Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review
Kwinten, Kevin J. J.
Lemain, Victor A.
de Hullu, Joanne A.
Leenders, William P. J.
Steenbeek, Miranda P.
van Altena, Anne M.
Pijnenborg, Johanna M. A.
CANCER MEDICINE, 2024, 13 (14):
[22] A comprehensive analysis of immunotherapy in advanced endometrial cancer (Review)
Wang, Liping
Liu, Lin
Huo, Da
Zhang, Yixiang
ONCOLOGY LETTERS, 2024, 27 (02)
[23] Recent management of endometrial cancer: a narrative review of the literature
Pados, George
Zouzoulas, Dimitrios
Tsolakidis, Dimitrios
FRONTIERS IN MEDICINE, 2024, 10
[24] Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer
Shafiee, Mohamad Nasir
Ortori, Catharine A.
Barrett, David A.
Mongan, Nigel P.
Abu, Jafaru
Atiomo, William
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 15
[25] Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship
Fader, Amanda Nickles
Arriba, Lucybeth Nieves
Frasure, Heidi E.
von Gruenigen, Vivian E.
GYNECOLOGIC ONCOLOGY, 2009, 114 (01) : 121 - 127
[26] Estrogens and the risk of breast cancer: A narrative review of literature
Al-Shami, Khayry
Awadi, Sajeda
Khamees, Almu'atasim
Alsheikh, Ahmad Malek
Al-Sharif, Sumaiya
Bereshy, Raneem Ala
Al-Eitan, Sharaf F.
Banikhaled, Sajedah H.
Al-Qudimat, Ahmad R.
Al-Zoubi, Raed M.
Zoubi, Mazhar Salim Al
HELIYON, 2023, 9 (09)
[27] Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
Dore, Molly
Filoche, Sara
Danielson, Kirsty
Henry, Claire
GYNECOLOGIC ONCOLOGY REPORTS, 2021, 36
[28] A narrative review of current and potential prognostic biomarkers for immunotherapy in small-cell lung cancer
Lim, Jeong Uk
Kang, Hye Seon
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (09)
[29] Narrative review of urinary glycan biomarkers in prostate cancer
Hatakeyama, Shingo
Yoneyama, Tohru
Tobisawa, Yuki
Yamamoto, Hayato
Ohyama, Chikara
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (04)
[30] New use of microsatellite instability analysis in endometrial cancer (Review)
Kunitomi, Haruko
Banno, Kouji
Yanokura, Megumi
Takeda, Takashi
Iijima, Moito
Nakamura, Kanako
Iida, Miho
Adachi, Masataka
Watanabe, Keiko
Matoba, Yusuke
Kobayashi, Yusuke
Tominaga, Eiichiro
Aoki, Daisuke
ONCOLOGY LETTERS, 2017, 14 (03) : 3297 - 3301

← 1 2 3 4 5 →